Campos J, del Carmen Núñez M, Rodríguez V, Entrena A, Hernández-Alcoceba R, Fernández F, Lacal J C, Gallo M A, Espinosa A
Departamento de Química Orgánica, Facultad de Farmacia, Campus de Cartuja s/n, E-18071, Granada, Spain.
Eur J Med Chem. 2001 Mar;36(3):215-25. doi: 10.1016/s0223-5234(01)01219-3.
Eleven derivatives of 1,1'-[1,2-ethylenebis(benzene-1,4-diylmethylene)]bis(4-pyridinium) dibromides bearing various groups at C-4 of the pyridinium moiety were synthesized and examined for their inhibition of choline kinase (ChoK) and antiproliferative activities. The C-4 substituents include electron-releasing, neutral or electron-withdrawing groups. A one-parameter regression equation has been derived which satisfactorily describes the ex vivo inhibitory potency of ChoK of the title compounds. The electronic effect plays a critical function in the ex vivo inhibition of ChoK although the role of electrostatic interactions could be altered due to a solvation process of both ChoK and ligands.
合成了11种1,1'-[1,2-亚乙基双(苯-1,4-二基亚甲基)]双(4-吡啶鎓)二溴化物的衍生物,这些衍生物在吡啶鎓部分的C-4位带有各种基团,并对它们抑制胆碱激酶(ChoK)的活性和抗增殖活性进行了研究。C-4位取代基包括供电子基团、中性基团或吸电子基团。推导了一个单参数回归方程,该方程令人满意地描述了标题化合物对ChoK的体外抑制效力。尽管由于ChoK和配体的溶剂化过程,静电相互作用的作用可能会改变,但电子效应在ChoK的体外抑制中起着关键作用。